Interestingly, the anti-inflammatory SCFAs might attenuate obesity-induced chronic inflammation that is partly modulated through inflammasome pathway [43, 44], especially nuclear factor-κB (NF-κB) and activator protein 1 [45, 46]. This evidence concerns the gene NFKB1 and obesity disorder.